share_log

Eli Lilly and Novo Want to Shake off Ozempic Copycats. Are They Ready to Meet Demand? -- Heard on the Street -- WSJ

Eli Lilly and Novo Want to Shake off Ozempic Copycats. Are They Ready to Meet Demand? -- Heard on the Street -- WSJ

禮來和諾和諾德想要擺脫Ozempic的仿製藥。他們準備好滿足需求了嗎?--《華爾街日報》街頭新聞--
WSJ ·  11/17 07:00

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論